Literature DB >> 8157719

Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH.

J Leger1, C Carel, I Legrand, A Paulsen, M Hassan, P Czernichow.   

Abstract

Measurement of muscle and fat tissue mass by magnetic resonance imaging of the thighs was used to study the metabolic effect of human (h) GH in 23 GH deficiency, 8 Turner's syndrome, and 14 intrauterine growth retardation prepubertal patients. They were evaluated before and 1, 3, 6, and 12 months after the onset of hGH treatment. Seven normal children were followed longitudinally as controls. During hGH treatment, a significant increase in muscle tissue and decrease in adipose tissue cross-sectional areas was observed, leading to a dramatic increase in the muscle/adipose tissue cross-sectional area ratio in each period studied. These findings remained highly significant when corrected for the small variation observed in controls. The body mass index was correlated with muscle and adipose tissue cross-sectional area at each time point (P < 0.0001). The muscle cross-sectional area increment correlated with the first year height velocity (P < 0.01). This study indicates that in children with and without GH deficiency, hGH therapy induces rapid and intense variation of muscle and adipose tissue mass, and that magnetic resonance imaging can be used to study some aspects of the metabolic actions of GH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157719     DOI: 10.1210/jcem.78.4.8157719

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Association Between the Growth Hormone/Insulin-Like Growth Factor-1 Axis and Muscle Density in Children and Adolescents of Short Stature.

Authors:  Guangzhi Yang; Qing Yang; Yanying Li; Yanhong Zhang; Shuxiong Chen; Dongye He; Mei Zhang; Bo Ban; Fupeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

2.  Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance.

Authors:  U Eiholzer; R Gisin; C Weinmann; S Kriemler; H Steinert; T Torresani; M Zachmann; A Prader
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

3.  Body composition in Egyptian Turner syndrome girls.

Authors:  Moushira Erfan Zaki; Hanan H Afifi
Journal:  Indian J Hum Genet       Date:  2013-04

Review 4.  A narrative review of skeletal muscle atrophy in critically ill children: pathogenesis and chronic sequelae.

Authors:  Chengsi Ong; Jan Hau Lee; Melvin K S Leow; Zudin A Puthucheary
Journal:  Transl Pediatr       Date:  2021-10

Review 5.  Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era.

Authors:  Annika Ritz; Eberhard Lurz; Michael Berger
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

6.  Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome.

Authors:  Hitoshi Kohno; Yutaka Igarashi; Keiichi Ozono; Kenji Ohyama; Masamichi Ogawa; Hisao Osada; Kazumichi Onigata; Susumu Kanzaki; Yoshiki Seino; Hiroaki Takahashi; Toshihiro Tajima; Katsuhiko Tachibana; Hiroyuki Tanaka; Yoshikazu Nishi; Tomonobu Hasegawa; Kenji Fujieda; Keinosuke Fujita; Reiko Horikawa; Susumu Yokoya; Toru Yorifuji; Toshiaki Tanaka
Journal:  Clin Pediatr Endocrinol       Date:  2012-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.